Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Novel HPV Vaccine in Healthy Female Subjects Vaccinated in the Primary Study

NCT00359619 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00359619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00359619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Novel HPV Vaccine in Healthy Female Subjects Vaccinated in the Primary Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
September 12, 2006
Completion date
January 30, 2007
Enrollment
383 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus, papillomavirus vaccines